Sarah Ernst

Sarah Ernst

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
View Bio
RSS

Latest Posts › Pharmaceutical Industry

Share:

Health Care Week in Review: DEA Issues Proposed Rules on Controlled Substances Prescribing via Telemedicine

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

3/7/2023  /  Controlled Substances , DEA , Department of Health and Human Services (HHS) , Electronic Prescribing , Food and Drug Administration (FDA) , Health Care Providers , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Telehealth , Telemedicine

Health Care Week in Review: CMMI Announces Three New Models, President Biden Issues Executive Order

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/20/2023  /  Abbreviated New Drug Application (ANDA) , Affordable Care Act , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry

Health Care Week in Review: State of the Union and HHS Guidance on Drug Rebates and PHE

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

2/13/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medical Devices , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs , Public Health Emergency , Vaccinations

Health Care Week in Review: Record-Breaking Marketplace Enrollments and Reproductive Healthcare Actions

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/30/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Pharmaceutical Industry , Reproductive Healthcare Issues

Health Care Week in Review: CMS Announces Increase in 2023 Medicare Accountable Care Relationships

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/23/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Pharmaceutical Industry , Popular

Health Care Week in Review: CMS and HHS Announce Residency Slots and Dates for Medicare Drug Negotiation

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/16/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: SAMHSA Releases NSDUH Survey Results, CMS Issues Medicaid Guidance

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

1/9/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , SAMHSA

Health Care Week in Review: Congress Passes Omnibus, HHS Releases Hospital Data

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/26/2022  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medical Devices , Medicare , Medicare Part B , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , SAMHSA , Telehealth

Health Care Week in Review: CMS and HHS Issue Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/20/2022  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: CMS Issues Prior Authorization Proposed Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/12/2022  /  Affordable Care Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Food and Drug Administration (FDA) , Health Care Providers , Health Insurance , Medicaid , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Vaccinations

Health Care Week in Review: The 2022 Midterm Election Results

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/15/2022  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Pharmaceutical Industry

Health Care Week in Review: CMS Released Four Major Annual Payment Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/7/2022  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Pharmaceutical Industry , Physician Fee Schedule , Popular , Prescription Drugs

Health Care Week in Review: Biden Administration Released a Final Rule on Surprise Billing

Below is Alston & Bird's Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/29/2022  /  Biden Administration , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Children's Health Insurance Program (CHIP) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , OIG , Pharmaceutical Industry , Surprise Medical Bills

Health Care Week in Review: HHS Announced Enhancing Oncology Model (EOM)

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/5/2022  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , Pharmaceutical Industry , Prescription Drugs

Alston & Bird Health Care Week in Review - May 2022 #1

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

5/9/2022  /  Centers for Disease Control and Prevention (CDC) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Investigational New Drug Application (IND) , Medicaid , Medical Devices , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Telehealth , Vaccinations
15 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide